Homocysteine in predicting the severity of coronary artery in patients with acute myocardial infarction
-
摘要: 目的:探索血同型半胱氨酸浓度与急性心肌梗死(AMI)患者冠脉病变严重程度的关系。方法:选取符合纳入及排除标准的AMI患者共118例。根据冠脉病变支数分为单支病变组(n=17)、双支病变组(n=25)和三支病变组(n=76);同时将这118例患者进行冠脉Gensini评分,并依据四分位数分为组1(n=29),组2(n=31),组3(n=29),组4(n=29)。分别比较年龄、性别、既往吸烟史、饮酒史、高血压史、糖尿病史、家族冠心病史;入院24 h内血总胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白、超氧化物歧化酶、同型半胱氨酸、随机血糖、N端-B型前脑钠肽及入院72 h内左室射血分数。结果:性别、同型半胱氨酸、随机血糖为冠脉病变支数的危险因素(P<0.05);同型半胱氨酸及左室射血分数为Gensini评分的危险因素(P<0.05)。结论:血同型半胱氨酸水平是预测AMI患者冠脉病变严重程度的重要标记物。
-
关键词:
- 急性心肌梗死 /
- 冠脉病变支数 /
- 冠脉Gensini评分 /
- 同型半胱氨酸
Abstract: Objective: To explore the relationship between homocysteine(Hcy)and the severity of coronary artery in patients with acute myocardial infarction(AMI).Methods: A total of 118 patients with acute myocardial infarction who met the inclusion and exclusion criteria of AMI were selected. Groups according to the numbers of coronary artery lesion: single vessel lesion group(n=17); double vessels lesion group(n=25); three vessels lesion group(n=76); Groups according to the quartile of Gensinis scores: group 1(n=29),group 2(n=31), group 3(n=29), group 4(n=29). Compare the differences of age, gender, history of hypertension, diabetes, smoking, drinking, and family history of coronary heart disease; the results of total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, superoxide dismutase, Hcy, random blood glucose, N-terminal B-type probrain natriuretic peptide within 24 hours after admission and left ventricular ejectin fraction within 72 hours.Results: Gender, Homocysteine and random blood glucose are risk factors for the numbers of coronary artery lesions(P<0.05); The Homocysteine, left ventricular ejection fraction are risk factors for Gensinis scores(P<0.05);Conclusion: Homocysteine is an important marker for the severity of coronary artery in patients with AMI. -
[1] Pilarczyk K,Werdan K,Russ M,et al.The German-Austrian S3 Guideline "Cardiogenic Shock Due to Myocardial Infarction:Diagnosis,Monitoring,and Treatment"[J].Thorac Cardiovasc Surg,2020.
[2] Lee CC,Huang SS,Yeo YH,et al.High-sensitivity-cardiac troponin for accelerated diagnosis of acute myocardial infarction:A systematic review and meta-analysis[J].Am J Emerg Med,2020,38(7):1402-1407.
[3] Zaric BL,Obradovic M,Bajic V,et al.Homocysteine and Hyperhomocysteinaemia[J].Curr Med Chem,2019,26(16):2948-2961.
[4] Hiraoka M,Kagawa Y.Genetic polymorphisms and folate status[J].Congenit Anom(Kyoto),2017,57(5):142-149.
[5] Katsiki N,Perez-Martinez P,Mikhailidis DP.Homocysteine and Non-Cardiac Vascular Disease[J].Curr Pharm Des,2017,23(22):3224-3232.
[6] Rampidis GP,Benetos G,Benz DC,et al.A guide for Gensini Score calculation[J].Atherosclerosis,2019,287:181-183.
[7] Kumar A,Palfrey HA,Pathak R,et al.The metabolism and significance of homocysteine in nutrition and health[J].Nutr Metab(Lond),2017,14:78.
[8] Skovierova H,Vidomanová E,Mahmood S,et al.The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health[J].Int J Mol Sci,2016,17(10):1733.
[9] Ma Y,Peng D,Liu C,et al.Serum high concentrations of homocysteine and low levels of folic acid and vitamin B(12) are significantly correlated with the categories of coronary artery diseases[J].BMC Cardiovasc Disord,2017,17(1):37-43.
[10] Cioni G,Marcucci R,Gori AM,et al.Increased homocysteine and lipoprotein(a)levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes[J].J Vasc Surg,2016,64(1):163-170.
[11] Ma Y,Li L,Geng XB,et al.Correlation Between Hyperhomocysteinemia and Outcomes of Patients With Acute Myocardial Infarction[J].Am J Ther,2016,23(6):e1464-e1468.
[12] Li S,Pan G,Chen H,et al.Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease[J].Heart Surg Forum,2019,22(3):E215-E217.
[13] Peng YP,Huang MY,Xue YJ,et al.Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention[J].Biomed Res Int,2020,2020:1710452.
[14] Fu Z,Qian G,Xue H,et al.Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome[J].Clin Interv Aging,2015,10:1467-1474.
[15] Liu C,Yang Y,Peng D,et al.Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease[J].Saudi Med J,2015,36(7):839-846.
[16] Zhan B,Xu Z,Zhang Y,et al.Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway[J].Biomed Pharmacother,2020,127:110-121.
[17] Ali F,Naqvi SA,Bismillah M,et al.Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients[J].Indian Heart J,2016.68(3):325-331.
[18] Ye J,Wang M,Xu Y,et al.Sestrins increase in patients with coronary artery disease and associate with the severity of coronary stenosis[J].Clin Chim Acta,2017,472:51-57.
[19] Calling S,Johansson SE,Wolff M,et al.The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area(WHILA):a 17-year follow-up cohort study[J].BMC Cardiovasc Disord,2019,19(1):239-247.
[20] Sarkar S,Paul BK,Chakraborty PK,et al.Association between Metabolic Syndrome and Acute Myocardial Infarction(AMI)[J].Mymensingh Med J,2016,25(4):628-634.
[21] Park JS,Cha KS,Lee HW,et al.Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction[J].Cardiol J,2019,26(2):176-185.
[22] Zhao X,Ai G,Qiu M,et al.Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention:CCC-ACS Project Analysis[J].Int J Cardiol,2020,310:1-8.
[23] Zhang C,Jiang L,Xu L,et al.Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease[J].Eur Heart J,2019,40(41):3397-3405.
计量
- 文章访问数: 144
- PDF下载数: 146
- 施引文献: 0